Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial

被引：0

作者：

Lee, B. ^{[1
]}

Hong, S. ^{[1
]}

Kim, J. ^{[1
,7
]}

Rha, S. ^{[2
]}

Heo, J. ^{[3
]}

Hur, S. ^{[4
]}

Choi, H. ^{[5
]}

Kim, K. ^{[6
]}

Kim, J. ^{[1
,7
]}

Kim, H. ^{[8
]}

Kim, W. ^{[9
]}

Choi, Y. ^{[10
]}

Kim, B. ^{[1
]}

Hong, M. ^{[1
]}

Jang, Y. ^{[11
]}

机构：

[1] Yonsei Univ, Seoul, South Korea

[2] Korea Univ, Guro Hosp, Seoul, South Korea

[3] Kosin Univ, Sch Med, Busan, South Korea

[4] Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea

[5] Hallym Univ, Chunchon, South Korea

[6] Ewha Womans Univ, Seoul, South Korea

[7] Chonnam Natl Univ Hosp, Gwangju, South Korea

[8] Chosun Univ Hosp, Gwangju, South Korea

[9] Yeungnam Univ Hosp, Daegu, South Korea

[10] Eulji Univ Hosp, Deajeon, South Korea

[11] Cha Bundang, Med Ctr, Seongnam, South Korea

来源：

EUROPEAN HEART JOURNAL | 2023年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：1

共 47 条

[41] Prevalent use of high-intensity statin therapy and LDL-C target attainment among PAD patients undergoing angioplasty A single-center retrospective cross-sectional analysis
Wolf, Simon
Spirk, David
Forgo, Gabor
Sebastian, Tim
Voci, Davide
Kucher, Nils
Barco, Stefano
[J]. VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2022, 51 (06) : 357 - 364
[42] ONE-YEAR CLINICAL OUTCOMES OF HIGH-INTENSITY VERSUS MODERATE TO LOW-INTENSITY STATIN THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: PROPENSITY-SCORE MATCHING ANALYSIS
Lee, Jung-Hee
Son, Byungchul
Kim, Ung
Lee, Chan-Hee
Son, Jang-Won
Park, Jong-Seon
Shin, Dong-Gu
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1389 - 1389
[43] TREATMENT PATTERNS AND LACK OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) GOAL ATTAINMENT AMONG HIGH-RISK PATIENTS USING HIGH OR MODERATE INTENSITY STATIN THERAPY IN GERMANY
Fox, K. M.
Fraass, U.
Hatz, M.
Qian, Y.
Tai, M.
[J]. VALUE IN HEALTH, 2017, 20 (09) : A603 - A603
[44] Relationship Between Baseline TRS2P Score and LDL-C Alone or in Combination in Predicting the Absolute Benefits of More Versus Less Intensive Statin Therapy in an ASCVD: Analysis From the TNT Trial
Nishikido, Toshiyuki
Fayyad, Rana
Melamed, Shari A.
Ray, Kausik K.
[J]. CIRCULATION, 2019, 140
[45] Measuring the Baseline Cholesterol Absorption and Synthesis Marker Can Predict the LDL-C Lowering Response to Ezetimibe-Statin Combination Therapy in Patients with Coronary Artery Disease: A Multi-Center Prospective Randomized Trial
Okada, Kozo
Fukuoka, Taku
Saitoh, Toshihiko
Endo, Tutomu
Uchino, Kazuaki
Fukui, Kazuaki
Kobayashi, Shunichi
Shimizu, Makoto
Iwasawa, Yuji
Morita, Yukiko
Wada, Atsushi
Shigemasa, Tomohiko
Mochida, Yasuyuki
Iwahashi, Noriaki
Umemura, Satoshi
Kimura, Kazuo
[J]. CIRCULATION, 2010, 122 (21)
[46] USE OF HIGH-INTENSITY STATIN THERAPY POST-ACUTE CORONARY SYNDROME IN THE ONGOING ODYSSEY OUTCOMES TRIAL OF ALIROCUMAB, A PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 MONOCLONAL ANTIBODY, VERSUS PLACEBO: INTERIM BASELINE DATA
Goodman, Shaun G.
Schwartz, Gregory
Bhatt, Deepak L.
Bittner, Vera
Diaz, Rafael
Hanotin, Corinne
Harrington, Robert
Jukema, Johan
Moryusef, Angele
Pordy, Robert
Roe, Matthew
Sasiela, William J.
Szarek, Michael
Tamby, Jean-Francois
White, Harvey
Zeiher, Andreas
Steg, Philippe
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 153 - 153
[47] Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial
Hong, Sung-Jin
Lee, Yong-Joon
Kang, Woong Chol
Hong, Bum-Kee
Lee, Jong-Young
Lee, Jin-Bae
Yang, Tae-Hyun
Yoon, Junghan
Lee, Seung-Jun
Ahn, Chul-Min
Kim, Jung-Sun
Kim, Byeong-Keuk
Ko, Young-Guk
Choi, Donghoon
Jang, Yangsoo
Hong, Myeong-Ki
[J]. CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)

← 1 2 3 4 5 →